Developing Novel IBD Therapeutics Using Artificial Intelligence & Machine Learning
Time: 2:30 pm
day: Day Two
Details:
- Utilizing artificial intelligence and computational modelling to identify enzyme based novel drug targets
- Harnessing artificial intelligence to identify novel biomarkers of IBD to better inform trial design and patient subgroup
- Leveraging machine learning to improve IBD data analysis
